One of the younger, more appealing real estate investment trusts (REITs) on the scene hasn't necessarily appealed to investors lately. Vici Properties (NYSE: VICI), which specializes in experiential properties -- primarily casinos -- is down nearly 12% in price over the past six months.

Biote: Revolutionizing Hormone Optimization Biote (NYSE: BTMD) represents an innovative play in the growing hormone optimization market.

To the disappointment of buy-and-hold investors, 2025 is shaping up to be a year where nimble traders are likely to see the biggest gains. That said, there’s nothing wrong with the steady performance offered by blue-chip stocks—a sound strategy for many investors.

At the current share price of $28, the stock is trading at a reasonable 29 times 2025 earnings estimates. Analysts currently expect Celsius to return to revenue growth in 2025 before accelerating to a double-digit increase in 2026. Assuming those estimates hold up, the stock offers enough value right now to support more gains.